Chemoinformaics analysis of 5-Galloylshikimic acid
| Molecular Weight | 326.257 | nRot | 3 |
| Heavy Atom Molecular Weight | 312.145 | nRig | 15 |
| Exact Molecular Weight | 326.064 | nRing | 2 |
| Solubility: LogS | -1.172 | nHRing | 0 |
| Solubility: LogP | 0.118 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 1 |
| nHetero | 9 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 9 | No. of Arom Bond | 6 |
| nHA | 8 | APOL | 39.9331 |
| nHD | 6 | BPOL | 17.5169 |
| QED | 0.372 |
| Synth | 3.747 |
| Natural Product Likeliness | 1.526 |
| NR-PPAR-gamma | 0.233 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.061 |
| HIA | 0.337 |
| CACO-2 | -6.116 |
| MDCK | 0.0000629 |
| BBB | 0.242 |
| PPB | 0.72898 |
| VDSS | 0.4 |
| FU | 0.17674 |
| CYP1A2-inh | 0.022 |
| CYP1A2-sub | 0.025 |
| CYP2c19-inh | 0.019 |
| CYP2c19-sub | 0.042 |
| CYP2c9-inh | 0.01 |
| CYP2c9-sub | 0.343 |
| CYP2d6-inh | 0.007 |
| CYP2d6-sub | 0.133 |
| CYP3a4-inh | 0.016 |
| CYP3a4-sub | 0.012 |
| CL | 14.374 |
| T12 | 0.976 |
| hERG | 0.006 |
| Ames | 0.02 |
| ROA | 0.009 |
| SkinSen | 0.104 |
| Carcinogencity | 0.015 |
| EI | 0.389 |
| Respiratory | 0.039 |
| NR-Aromatase | 0.007 |
| Antiviral | No |
| Prediction | 0.520406 |